Skip to main content
. 2018 Jun 28;8(3):172–185. doi: 10.1159/000489319

Fig. 5.

Fig. 5

Survival figures. a Probabilities of tumor progression-free survival in 74 naïve patients treated with multibipolar radiofrequency ablation (RFA) for hepatocellular carcinomas (HCC) > 5 cm (median: 17.4 months). b Probabilities of tumor progression-free survival in naïve patients after multibipolar RFA for the treatment of HCC > 5 cm according to the tumor type: mass-forming (n = 57) (median: 11.5 months) vs. infiltrative form (n = 17) (median: 29.7 months). c Probabilities of overall survival in 74 naïve patients treated with multibipolar RFA for HCC > 5 cm (median: 37.2 months). d Probabilities of overall survival in naïve patients after multibipolar RFA for the treatment of HCC > 5 cm according to the tumor type: mass forming (n = 57) (median: 21.8 months) vs. infiltrative form (n = 17) (median: 41.8 months).